Lab Automation Market is forecast to expand at a CAGR of over 7% until 2031

The global lab automation market is forecast to surpass the valuation of US$ 1 trillion by end of 2031. According to a study by Fact MR, the market is demonstrating a steady growth due to rising demand for precision-based diagnostics and medicine delivery. As per a report by Fact.MR, the global lab automation market is estimated to expand at a CAGR of over 7% for the forecast period between 2021 and 2031.

According to Institute for Human Data Science, patients gained over 1.8 trillion days of therapy across all countries, average 234 days per patient. It also forecasts that global health expenditure will grow at a rate of 2 to 5% per year, surpassing US$ 1 trillion by 2024. Thus, the rising demand for effective treatment will present a lucrative growth opportunity for the market.


Request a report sample to gain comprehensive insights at


According to the report, the market is poised to experience significant gains, posting a CAGR exceeding 7% through 2031. Increasing number of grants disbursed to facilitate advanced drug development & clinical diagnostic research is responsible for bulk of the market’s growth. For instance, the EU Commission, in March 2021, advanced a grant to eTheRNA Immunotherapies, to accelerate the development of a novel and potentially best-in-class therapeutic mRNA cancer vaccine to treat recurrent HPV16+ head and neck cancers. The grant amounted to € 6.9 million.

Growth prospects have further heightened since the onset of COVID-19, with healthcare providers scrambling to deploy precise and advanced diagnostic services, as well as accelerate drug and vaccine development. Consequently, overall healthcare spending rose to US$ 1.4 trillion, representing over 30% increase since 2015. Additionally, a host of government initiatives in key markets have greatly helped augment spending on lab automation, a trend likely to continue over the coming years.

lab automation market
Key Takeaways from Market Study
  • By product, demand for integrated automated workstations to expand at a rapid pace
  • Biotechnology & pharmaceutical industry experiencing major uptake of lab automation systems
  • By application, drug discovery and clinical diagnostics to collectively capture a lucrative share
  • Voluminous biopharmaceuticals manufacturing to elevate lab automation deployment across the U.S.
  • The U.K. to generate fresh revenue ecosystems amid high reliance on in vitro diagnostics
  • Growing R&D initiatives by government and non-governmental entities bolstering France and Germany’s growth prospects
  • India and China to emerge as lucrative hotspots amid increasing need to offset asymmetries in efficient lab testing mechanisms

“Growing irregularities in quality diagnosis & drug development due to high error margins are prompting healthcare providers to invest in the most contemporary lab automation solutions, driving market growth,”comments a Fact.MR analyst.

Request Methodology & Get a Glimpse of Our Expertise


Competitive Landscape

Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Hudson Robotics, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Hamilton Robotics, Bio-Rad Laboratories, bioMerieux SA, Becton Dickinson & Company, Qiagen NV, Danaher Corporation, and Hudson Robotics are some prominent lab automation equipment and software providers profiled in Fact.MR’s report.

  • With regard to solution offerings, Siemens Healthineers provides the SIMATIC SIPAT Process Analytical Technology, facilitating the right-first-time production via Quality by Design (QbD) transfer of previously downstream quality controls into the manufacturing process itself. The software helps healthcare settings become more flexible with regard to production expansion, new product launches, and entry into new markets.
  • Similarly, Bio-Rad Laboratories offers its CFX Automation System II, a robotic plate handler compatible with all CFX RT-PCR Detection Systems to enable walk-away, high throughput qPCR operation in a simplified format. This systems generates large volumes of data and rapid data analysis. It is ideally suited to meet the high throughput RT-PCR requirements of today’s drug discovery and screening workflows.


Get More Insights-

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the global lab automation market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (equipment and software & informatics), application (drug discovery, clinical diagnostics, genomic solutions, and proteomics solutions), and end-user (biotechnology & pharmaceutical industries, research & academic institutes, hospitals & diagnostic laboratories, forensic laboratories, environmental testing labs, and food & beverage industry), across five major regions of the world.


Explore Fact.MR’s Coverage on the Healthcare Domain

Lab Workflow Solutions Market – The expanding popularity of synthetic pharmaceuticals across pharmacotherapies, particularly in developed nations such as North America and Europe, is assisting the synthetic pharmaceuticals market to grow at a large rate. Increased demand for lab workflow solutions could be due to a variety of factors, including rising lab operational costs.

Synthetic Drugs Market – During the forecast period, the development of novel methodologies in the global synthetic drugs market will fuel the market’s growth. Through these purchases, the market’s producers hope to expand their synthetic drug product offerings for the consumer, nutraceutical, and pharmaceutical sectors.

Drug Discovery Services Market – Fact.MR study analyses the worldwide drug discovery services market and provides readers with an unbiased and accurate analysis. Some of the causes driving the rise of drug discovery services include an increase in research and development activity and expenditures, as well as prominent pharmaceutical corporations shifting toward outsourcing.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website:
Research Insight:
Press Release: